Incidence Rate of Heart Failure After Acute Myocardial Infarction With Optimal Treatment

Last updated: September 29, 2021
Sponsor: Harbin Medical University
Overall Status: Completed

Phase

N/A

Condition

Heart Failure

Myocardial Ischemia

Coronary Artery Disease

Treatment

N/A

Clinical Study ID

NCT03297164
2016YFC1301101
  • Ages > 18
  • All Genders

Study Summary

The main purpose of this study is to build a multi-center, prospective and regionally representative acute myocardial infarction(AMI) cohort，and build a study platform for heart failure caused by AMI; To explore the 1 year incidence rate of heart failure after AMI given the optimized treatment and the treatment model affecting the incidence rate of heart failure, and finally to reduce the incidence rate of heart failure by 5%.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • age≥18 years
  • diagnosed acute myocardial infarction
  • signed the informed consent form

Exclusion

Exclusion Criteria:

  • AMI is caused by surgery, trauma, gastrointestinal bleeding or complications of PCI;
  • AMI occurred in patients who have been hospitalized for other reasons;
  • patients with previous history of chronic heart failure;
  • researchers judging that patient's compliance was poor and could not complete thestudy according to the requirements.
  • life expectancy is less than 12 months;
  • heart transplant patients;
  • patients with tumors;

Study Design

Total Participants: 12043
Study Start date:
December 21, 2017
Estimated Completion Date:
June 30, 2021

Study Description

the study aim to enroll 12000 acute myocardial infartion (AMI) patients, including ST-segment elevation myocardial infarction (STEMI) and non ST-segment elevation myocardial infarction (NSETMI), Patients were divided into two groups(optimized group and un-optimized group) according to treatment models they accepted in 20 reginally representative hosptials of China. whether optimizaed or not is judged by 4 four aspects,including emergency treatment procedure, pre-infusion medication, reperfusion strategy selection, and early rehabilitation after reperfusion.Patients were followed at 1 month, 6 months and 12 months. The physical condition and clinical events(heart failure, death, re-infarction, revascularization, apoplexy, malignant arrhythmias, bleeding events, other adverse events)were collected at follow up.

Connect with a study center

  • Beijing An Zhen Hospital, Capital Medical University

    Beijing, Beijing 100029
    China

    Site Not Available

  • Beijing Chao-Yang Hospital, Capital Medical University

    Beijing, Beijing
    China

    Site Not Available

  • Peking Univerisity People'Hospital

    Beijing, Beijing 100044
    China

    Site Not Available

  • Peking University First Hospital

    Beijing, Beijing
    China

    Site Not Available

  • Guangdong general hospital

    Guangzhou, Guangdong
    China

    Site Not Available

  • The first affiliated hospital of Guangxi medical university

    Nanning, Guangxi 530021
    China

    Site Not Available

  • Second hospital of hebei medical university

    Shijiazhuang, Hebei
    China

    Site Not Available

  • Daqing Oilfield General Hospital

    Daqing, Heilongjiang 163001
    China

    Site Not Available

  • The first affiliated hospital of Zhengzhou medical university

    Zhengzhou, Henan
    China

    Site Not Available

  • Zhongda Hospital Southeast University

    Nanjing, Jiangsu 210009
    China

    Site Not Available

  • The Second Affiliated Hospital of Nanchang University

    Nanchang, Jiangxi 330006
    China

    Site Not Available

  • The Second Hospital of Jilin University

    Changchun, Jilin 130000
    China

    Site Not Available

  • the second affiliated hospital of Dalian medical university

    Dalian, Liaoning
    China

    Site Not Available

  • Shenyang military district general hospital of the people's liberation army

    Shenyang, Liaoning
    China

    Site Not Available

  • The first affiliated hospital of military medical university

    Xi'an, Shanxi
    China

    Site Not Available

  • Third Military Medical University

    Chongqing, Sichuan
    China

    Site Not Available

  • The General Hospital of Tianjin Medical University

    Tianjin, Tianjin
    China

    Site Not Available

  • Tianjin Chest Hospital

    Tianjing, Tianjin
    China

    Site Not Available

  • The First Affiliated Hospital of Xinjiang Medical University

    Urumqi, Xinjiang
    China

    Site Not Available

Map preview placeholder

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.